Hellen Gelband focuses on health policy issues in the United States and internationally. During her career, she has used the evaluation of medical evidence to inform a wide range of both American and global health policies. Her work at RFF explores the growing resistance to antibiotic and anti-malarial drugs, as well as access to and cost of such pharmaceuticals. She is coordinating the Global Antibiotic Resistance Partnership – a project that will establish centers in five developing countries to foster rational policies governing the use of antibiotics.